ATG5 and colorectal carcinoma: Similarly, a Cox regression analysis with adjustments for cell differentiation and AJCC pathological stage showed that an increased protein level of ATG5 had a higher hazard ratio in patients with CRC (AHR: 1.95, p = 0.045, Table 3).